Citadel Advisors’s Sensei Biotherapeutics SNSE Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q1 | – | Sell |
-2,886
| Closed | -$28.3K | – | 6850 |
|
|
2024
Q4 | $28.3K | Sell |
2,886
-416
| -13% | -$4.08K | ﹤0.01% | 5588 |
|
|
2024
Q3 | $39.5K | Buy |
3,302
+2,534
| +330% | +$30.3K | ﹤0.01% | 5177 |
|
|
2024
Q2 | $9.53K | Sell |
768
-425
| -36% | -$5.27K | ﹤0.01% | 5522 |
|
|
2024
Q1 | $25.1K | Sell |
1,193
-97
| -8% | -$2.04K | ﹤0.01% | 5500 |
|
|
2023
Q4 | $17.9K | Buy |
+1,290
| New | +$17.9K | ﹤0.01% | 5403 |
|
|
2022
Q3 | – | Sell |
-2,969
| Closed | -$134K | – | 6647 |
|
|
2022
Q2 | $134K | Buy |
+2,969
| New | +$134K | ﹤0.01% | 5170 |
|
|
2021
Q4 | – | Sell |
-6,163
| Closed | -$1.3M | – | 7132 |
|
|
2021
Q3 | $1.3M | Sell |
6,163
-8,020
| -57% | -$1.69M | ﹤0.01% | 3484 |
|
|
2021
Q2 | $2.77M | Sell |
14,183
-20,444
| -59% | -$3.99M | ﹤0.01% | 2853 |
|
|
2021
Q1 | $10.1M | Buy |
+34,627
| New | +$10.1M | ﹤0.01% | 1430 |
|